tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX

Neurocrine (NBIX) Cash flow

1,145 Followers

Neurocrine Cash Flow

NBIX's free cash flow for Q4 2023 was $118.10M. For the 2023 fiscal year, NBIX's free cash flow was decreased by $38.70M and operating cash flow was $123.50M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 389.90M$ 389.90M$ 339.40M$ 256.50M$ 228.50M$ 147.00M
Investing Cash Flow
$ -467.10M$ -467.10M$ -177.10M$ -130.20M$ 4.10M$ -211.10M
Financing Cash Flow
$ 65.30M$ 65.30M$ -234.30M$ 27.40M$ -157.80M$ 32.40M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 834.78M$ 259.10M$ 270.70M$ 344.00M$ 190.30M$ 115.50M
Income Tax Paid Supplemental Data
$ 51.50M$ 51.50M$ 14.40M$ 5.10M$ 15.30M$ 500.00K
Interest Paid Supplemental Data
$ 3.80M$ 3.80M$ 6.60M$ 8.60M$ 11.60M$ 11.60M
Issuance Of Capital Stock
$ 65.30M$ 65.30M$ 44.70M$ 27.50M-$ 27.31M
Issuance Of Debt
--$ -279.00M$ -100.00K-$ 0.00
Repayment Of Debt
--$ -279.00M$ -100.00K$ -186.90M$ 0.00
Free Cash Flow
$ 361.60M$ 361.60M$ 322.90M$ 233.10M$ 217.60M$ 132.30M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Neurocrine Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis